🇺🇸 FDA
Patent

US 6693108

Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases

expired A61KA61K31/341A61K31/4155

Quick answer

US patent 6693108 (Inhibitors of c-JUN N terminal kinases (JNK) and other protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/341, A61K31/4155, A61K31/4192, A61K31/42